Results 251 to 260 of about 212,106 (307)

Visual Recovery Reflects Cortical MeCP2 Sensitivity in Rett Syndrome

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rett syndrome (RTT) is a devastating neurodevelopmental disorder with developmental regression affecting motor, sensory, and cognitive functions. Sensory disruptions contribute to the complex behavioral and cognitive difficulties and represent an important target for therapeutic interventions.
Alex Joseph Simon, Nathalie Picard, Valeria d'Andrea, Enchi Chang, Joseph Leffler, Eleonora Centofante, Matthew Taylor, Francesca Bardi, Francesca Cavicchiolo, Takao K. Hensch, Stefano Panzeri, Chinfei Chen, Michela Fagiolini   +12 more
wiley   +1 more source

Utility of ctDNA-molecular residual disease in predicting minimal residual disease in non-small cell lung cancer patients after radical resection. [PDF]

Transl Lung Cancer Res
Masago K, Horio Y, Sasaki E, Fujita S.
europepmc   +1 more source

The Impact of Tilburg Frailty on Poststroke Fatigue in First‐Ever Stroke Patients: A Cross‐Sectional Study With Unified Measurement Tools and Improved Statistics

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Poststroke fatigue (PSF) and frailty share substantial overlap in their manifestations, yet previous research has yielded conflicting results due to the use of heterogeneous frailty assessment tools. Objective To evaluate the independent impact of frailty on PSF using a unified measurement system (Tilburg Frailty Indicator, TFI ...
Chuan‐Bang Chen, Xiao‐Xue Wang, Shao‐Rui Bao, Sui‐Li Lin, Mei‐Chun Shu, Xi‐Xi Ye, Wen‐Jie Cong   +6 more
wiley   +1 more source

Minimal residual disease measurement in blood by mass spectrometry identifies long-term responders in multiple myeloma. [PDF]

Blood Neoplasia
Kubicki T, Derman BA, Cooperrider JH, Puła A, Barnidge D, Dytfeld D, Jiang K, Jakubowiak AJ.   +7 more
europepmc   +1 more source

Systemic T Cell Receptor Profiling Reveals Adaptive Immune Activation and Potential Immune Signatures of Diagnosis and Brain Atrophy in Epilepsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Epilepsy is increasingly associated with immune dysregulation and inflammation. The T cell receptor (TCR), a key mediator of adaptive immunity, shows repertoire alterations in various immune‐mediated diseases. The unique TCR sequence serves as a molecular barcode for T cells, and clonal expansion accompanied by reduced overall TCR ...
Yong‐Won Shin, Sang Bin Hong, Yong Woo Shin, Inpyeong Hwang, Jaeseong Oh, Jihyeon Choi, Narae Kim, Jangsup Moon, Keun‐Hwa Jung, Kyung‐Il Park, Ki‐Young Jung, Kon Chu, Sang Kun Lee   +12 more
wiley   +1 more source

Sensitive detection of minimal residual disease and immunotherapy targets by multi-modal bone marrow analysis in high-risk neuroblastoma - a multi-center study. [PDF]

J Exp Clin Cancer Res
Gelineau NU, Bozsaky E, van Zogchel LMJ, Rifatbegovic F, Lazic D, Ziegler A, Javadi A, Zappeij-Kannegieter L, Pötschger U, Fiocco M, Ambros PF, Ambros IM, Bodenmiller B, van der Schoot EC, Ladenstein R, Bernkopf M, Tytgat GAM, Taschner-Mandl S.   +17 more
europepmc   +1 more source

Persistent BCR::ABL1 p190 Minimal Residual Disease and Declining Donor Chimerism Following Haploidentical Bone Marrow Transplant in Pediatric Acute Myeloid Leukemia With Dual High-Risk Fusions. [PDF]

Cureus
Bafail MA, PeerZada A, Alrajeh R, Alseraya FM, AlJurayb HS.   +4 more
europepmc   +1 more source

7. Minimal Residual Disease

Annals of Oncology, 2002
openaire   +1 more source

Minimal Residual Disease Detection in Peripheral Blood of Patients With High-Risk Neuroblastoma Correlates With Outcome in the International GPOH-DCOG Prospective Validation Study. [PDF]

JCO Precis Oncol
Gelineau NU, van Zogchel LMJ, De Carolis B, van Wezel EM, Zappeij-Kannegieter L, Javadi A, Schumacher-Kuckelkorn R, Simon T, Berthold F, van Noesel MM, Fiocco M, Stutterheim J, Ellen van der Schoot C, Hero B, Tytgat GAM.   +14 more
europepmc   +1 more source

A comprehensive overview of minimal residual disease in the management of early-stage and locally advanced non-small cell lung cancer. [PDF]

NPJ Precis Oncol
Boukouris AE, Michaelidou K, Joosse SA, Charpidou A, Mavroudis D, Syrigos KN, Agelaki S.   +6 more
europepmc   +1 more source